Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
Vancouver, British Columbia – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes and in controlled patient markets,
June 15, 2023
